...
首页> 外文期刊>Digestive Diseases and Sciences >Clinical Significance of Genotypes and Precore/Basal Core Promoter Mutations in HBV Related Chronic Liver Disease Patients in North India
【24h】

Clinical Significance of Genotypes and Precore/Basal Core Promoter Mutations in HBV Related Chronic Liver Disease Patients in North India

机译:印度北部HBV相关慢性肝病患者基因型和前核心/基础核心启动子突变的临床意义

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose Data on genotypes, basal core promoter (BCP) and precore mutants of hepatitis B virus and their association with different HBV related liver disease have been studied inadequately and are controversial. Thus, the aim of this study was to determine the incidence of BCP and precore HBV mutants and their relationship with HBV genotype and different stages of HBV related liver disease in North Indian patients. Methods A total 273 patients with different stages of HBV related liver diseases were enrolled. Nested poly-merase chain reaction (PCR) was used to amplify the BCP/ PC regions. RFLP and direct sequencing were performed to validate the mutations identified in these regions. HBV genotyping was accomplished by multiplex PCR. Results Genotype D was the predominant genotype found in each of the various HBV related liver diseases. The BCP mutation was found significantly more often in inactive carriers and compensated cirrhosis as compared to the other groups. The BCP mutation was present in 29.1% of patients with genotype D versus 17.1% with genotype A (P = 0.001). The precore mutation was also more frequently observed with genotype D compared with genotype A (36.9 vs. 4.8%, P = 0.0007). Conclusion Genotype D is predominant in North Indian patients. The BCP and precore mutations occur in one-third of HBV positive patients in association with the genotype D. We did not find any correlation with severity of liver disease with genotypes and mutations.
机译:目的关于乙型肝炎病毒的基因型,基础核心启动子(BCP)和前核心突变体及其与不同的HBV相关性肝病的关系的数据研究不足,并存在争议。因此,本研究的目的是确定北印度患者中BCP和前核心HBV突变的发生率及其与HBV基因型和HBV相关肝病不同阶段的关系。方法纳入273例不同阶段的HBV相关肝病患者。巢式聚合酶链反应(PCR)用于扩增BCP / PC区。进行RFLP和直接测序以验证在这些区域中鉴定的突变。 HBV基因分型通过多重PCR完成。结果基因型D是在各种HBV相关肝病中发现的主要基因型。与其他组相比,在非活动性携带者和代偿性肝硬化中发现BCP突变的频率更高。 BCP突变在基因型D的患者中占29.1%,而在基因型A的患者中占17.1%(P = 0.001)。与基因型A相比,基因型D的前核心突变也更常见(36.9比4.8%,P = 0.0007)。结论D型基因型在北印度人患者中占主导地位。 BCP和前核突变在与基因型D相关的HBV阳性患者中发生三分之一。我们没有发现与基因型和突变与肝病严重程度的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号